This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Agarwal N, Sadhukhan P. Therapeutic Insights against Oxidative Stress Induced Diabetic Nephropathy: A Review. J Autoimmune Disord. 2015; 1: 1–17.AgarwalNSadhukhanPTherapeutic Insights against Oxidative Stress Induced Diabetic Nephropathy: A Review2015111710.21767/2471-8153.100002Search in Google Scholar
Ahmad A, Mondello S, Di Paola R et al. Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: A comparison with n-acetylcysteine. Eur J Pharmacol. 2012; 674: 397–406.AhmadAMondelloSDi PaolaRProtective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: A comparison with n-acetylcysteine201267439740610.1016/j.ejphar.2011.10.04122094062Search in Google Scholar
Ahmadi A, Mazooji N, Roozbeh J, Mazloom Z, Hasanzade J. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflammation, and malnutrition in hemodialysis patients. Iran J Kidney Dis. 2013; 7: 461–467.AhmadiAMazoojiNRoozbehJMazloomZHasanzadeJEffect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflammation, and malnutrition in hemodialysis patients20137461467Search in Google Scholar
Ahmadvand H. Effects of coenzyme Q10 on hemoglobin A1C, serum urea and creatinine in alloxan-induced Type 1 diabetic rats. Iran J Pharmacol Ther. 2012; 11: 64–67.AhmadvandHEffects of coenzyme Q10 on hemoglobin A1C, serum urea and creatinine in alloxan-induced Type 1 diabetic rats2012116467Search in Google Scholar
Alam M, Rahman M. Mitochondrial dysfunction in obesity: Potential benefit and mechanism of co-enzyme Q10 supplementation in metabolic syndrome. J Diabetes Metab Disord. 2014; 13: 1–11.AlamMRahmanMMitochondrial dysfunction in obesity: Potential benefit and mechanism of co-enzyme Q10 supplementation in metabolic syndrome20141311110.1186/2251-6581-13-60405756724932457Search in Google Scholar
Algenstaedt P, Schaefer C, Biermann T, et al. Microvascular Alterations in Diabetic Mice Correlate with Level of Hyperglycemia. Diabetes. 2003; 52: 542–549.AlgenstaedtPSchaeferCBiermannTMicrovascular Alterations in Diabetic Mice Correlate with Level of Hyperglycemia20035254254910.2337/diabetes.52.2.54212540633Search in Google Scholar
Amin M, Asaad G, Abdel Salam R, El-Abhar H, Arbid M. Novel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin in Insulin Resistant/Diabetic Rats. PLoS One. 2014; 9: e89169.AminMAsaadGAbdel SalamREl-AbharHArbidMNovel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin in Insulin Resistant/Diabetic Rats20149e8916910.1371/journal.pone.0089169393067524586567Search in Google Scholar
Ammon HP, Muller PH, Eggstein M, Wintermantel C, Aigner B, Safayhi H, et al. Increase in glucose consumption by acetylcysteine during hyperglycemic clamp. A study with healthy volunteers. Arzneimittelforsch. 1992; 42: 642–645.AmmonHPMullerPHEggsteinMWintermantelCAignerBSafayhiHIncrease in glucose consumption by acetylcysteine during hyperglycemic clamp. A study with healthy volunteers199242642645Search in Google Scholar
Anwar M, Abd El-Moniem M, Megahed H, EL-Toukhy S, Mohammed N, Youness E. Effect of Coenzyme Q10 Supplementation on Markers of Oxidative Stress in Streptozotocin Induced Diabetic Rats. Journal of Applied Pharmaceutical Science. 2014; 4: 9–15.AnwarMAbd El-MoniemMMegahedHEL-ToukhySMohammedNYounessEEffect of Coenzyme Q10 Supplementation on Markers of Oxidative Stress in Streptozotocin Induced Diabetic Rats2014491510.7324/JAPS.2014.40602Search in Google Scholar
Ates O, Bilen H, Keles S, Alp H, Keles M, et al. Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy. Int J Ophthalmol. 2013; 6: 675–679.AtesOBilenHKelesSAlpHKelesMPlasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy20136675679Search in Google Scholar
Badole SL, Bagul PP, Mahamuni SP et al. Oral L-glutamine increases active GLP-1 (7–36) amide secretion and improves glycemic control in streptozotocin-nicotinamide induced diabetic rats. ChemBiol Interact. 2013; 203: 530–541.BadoleSLBagulPPMahamuniSPOral L-glutamine increases active GLP-1 (7–36) amide secretion and improves glycemic control in streptozotocin-nicotinamide induced diabetic rats201320353054110.1016/j.cbi.2013.02.00623466488Search in Google Scholar
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414: 813–20.BrownleeMBiochemistry and molecular cell biology of diabetic complications20014148132010.1038/414813a11742414Search in Google Scholar
Dabla PK. Renal function in diabetic nephropathy. World J Diabetes. 2010; 1: 48–56.DablaPKRenal function in diabetic nephropathy20101485610.4239/wjd.v1.i2.48308388221537427Search in Google Scholar
Garjani A, Andalib S, Biabani S, Soraya H, Doustar Y, et al. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Eur J Pharmacol. 2011; 666: 135–141.GarjaniAAndalibSBiabaniSSorayaHDoustarYCombined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat201166613514110.1016/j.ejphar.2011.04.06121570962Search in Google Scholar
Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, et al. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med. 2009; 15: 1298–1306.GeraldesPHiraoka-YamamotoJMatsumotoMClermontALeitgesMActivation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy2009151298130610.1038/nm.2052329090619881493Search in Google Scholar
Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotinamide induced rat model of type 2 diabetes. Acta Physiol Hung. 2014; 101: 408–420.GhasemiAKhalifiSJediSStreptozotocin-nicotinamide induced rat model of type 2 diabetes201410140842010.1556/APhysiol.101.2014.4.225532953Search in Google Scholar
Haber CA, Lam TK, Yu Z et al. N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab. 2003; 285: E744–E753.HaberCALamTKYuZN-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress2003285E744E75310.1152/ajpendo.00355.200212799318Search in Google Scholar
Haraldsson B, Sörensson J. Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci. 2004; 19: 7–10.HaraldssonBSörenssonJWhy do we not all have proteinuria? An update of our current understanding of the glomerular barrier20041971010.1152/nips.01461.200314739395Search in Google Scholar
Hasegawa G, Yamamoto Y, Zhi J, Tanino Y, Yamasaki M, et al. Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia. Acta Diabetol. 2005; 42: 179–181.HasegawaGYamamotoYZhiJTaninoYYamasakiMDaily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia20054217918110.1007/s00592-005-0199-616382305Search in Google Scholar
Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits NF-kappaB activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J. 1999; 13: 1845–1854.HoEChenGBrayTMSupplementation of N-acetylcysteine inhibits NF-kappaB activation and protects against alloxan-induced diabetes in CD-1 mice1999131845185410.1096/fasebj.13.13.1845Search in Google Scholar
Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002; 56: 1137–1142.HodgsonJMWattsGFPlayfordDABurkeVCroftKDCoenzyme Q10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes2002561137114210.1038/sj.ejcn.160146412428181Search in Google Scholar
Idris I, Gray S, Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia. 2001; 44: 659–673.IdrisIGraySDonnellyRProtein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes20014465967310.1007/s00125005167511440359Search in Google Scholar
Jemai H, El Feki A, Sayadi S. Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J Agric Food Chem. 2009; 57: 8798–8804.JemaiHEl FekiASayadiSAntidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats2009578798880410.1021/jf901280r19725535Search in Google Scholar
Kisic B, Miric D, Dragojevic I, Rasic J, Popovic L. Role of Myeloperoxidase in Patients with Chronic Kidney Disease. Oxid Med Cell Longev. 2016; 1–10.KisicBMiricDDragojevicIRasicJPopovicLRole of Myeloperoxidase in Patients with Chronic Kidney Disease201611010.1155/2016/1069743483415127127544Search in Google Scholar
Kohei KA. Pathophysiology of type 2 diabetes and its treatment policy. JMAJ. 2010; 53: 41–46.KoheiKAPathophysiology of type 2 diabetes and its treatment policy2010534146Search in Google Scholar
Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World J Diabetes. 2019; 10: 1–15.KrhačMLovrenčićMVUpdate on biomarkers of glycemic control20191011510.4239/wjd.v10.i1.1634765430697366Search in Google Scholar
Lee ES, Kim HM, Kang JS, Lee EY, et al. Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model. Nephrol Dial Transplant. 2016; 3: 391–400.LeeESKimHMKangJSLeeEYOleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model2016339140010.1093/ndt/gfv37726567248Search in Google Scholar
Mahajan MS, Gulecha VS, Upaganlawar AB, Upasani CD. Antioxidant Defense in Diabetic Nephropathy In: Uddin S & Upaganlawar AB: Oxidative Stress and Antioxidant Defense: Biomedical value in Health and Diseases, 1st ed. New York: Nova; 2019.MahajanMSGulechaVSUpaganlawarABUpasaniCDAntioxidant Defense in Diabetic NephropathyIn:UddinSUpaganlawarAB1st ed.New YorkNova2019Search in Google Scholar
Maheshwari R, Balaraman R, Sen AK, Shukla D, Seth A. Effect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats. Renal Failure. 2017; 39: 130–139.MaheshwariRBalaramanRSenAKShuklaDSethAEffect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats20173913013910.1080/0886022X.2016.1254659601450627841100Search in Google Scholar
Maheshwari RA, Balaraman R, Sen AK, Seth AK. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats. Indian J Pharmacol. 2014; 46: 627–32.MaheshwariRABalaramanRSenAKSethAKEffect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats2014466273210.4103/0253-7613.144924426407925538335Search in Google Scholar
Maitra A. The Endocrine System. in: Kumar V, Abbas A, Fausto N, Aster J. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia: Elsevier Saunders; 2015.MaitraAThe Endocrine Systemin:KumarVAbbasAFaustoNAsterJ9th ed.PhiladelphiaElsevier Saunders201510.1016/B978-1-4377-0792-2.50029-8Search in Google Scholar
Masharani, U. Diabetes Mellitus and hypoglycemia. In: McPhee SJ, Papadakis MA, Tierney LM. Current medical diagnosis and treatment, 47th ed. New York: McGraw-Hill; 2008.MasharaniUDiabetes Mellitus and hypoglycemiaIn:McPheeSJPapadakisMATierneyLM47th ed.New YorkMcGraw-Hill2008Search in Google Scholar
Mezawa M, Takemoto M, Onishi S, Ishibashi R, Ishikawa T, Yamaga, M, et al. The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study. Biofactors. 2012; 38: 416–421.MezawaMTakemotoMOnishiSIshibashiRIshikawaTYamagaMThe reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study20123841642110.1002/biof.103822887051Search in Google Scholar
Midaoui A, Ismael M, Lu H, Fantus I, de Champlain J, Couture R. Comparative effects of N-acetyl-L-cysteineand ramipril on arterial hypertension, insulin resistance, andoxidative stress in chronically glucose-fed rats. Can J Physiol Pharmacol. 2008; 86: 752–60MidaouiAIsmaelMLuHFantusIde ChamplainJCoutureRComparative effects of N-acetyl-L-cysteineand ramipril on arterial hypertension, insulin resistance, andoxidative stress in chronically glucose-fed rats2008867526010.1139/Y08-09019011670Search in Google Scholar
Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease. Origin and development of ideas. Diabetologia. 1999; 42: 263–285.MogensenCEMicroalbuminuria, blood pressure and diabetic renal disease. Origin and development of ideas19994226328510.1007/s00125005115110096778Search in Google Scholar
Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983; 32: 64–78.MogensenCEChristensenCKVittinghusEThe stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy198332647810.2337/diab.32.2.S646400670Search in Google Scholar
Mora-Fernández C, Domínguez-Pimentel V, de Fuentes MM, et al. Diabetic kidney disease: from physiology to therapeutics. J Physiol. 2014; 592: 3997–4012.Mora-FernándezCDomínguez-PimentelVde FuentesMMDiabetic kidney disease: from physiology to therapeutics20145923997401210.1113/jphysiol.2014.272328419801024907306Search in Google Scholar
Odetti P, Pesce C, Traverso N, Menini S, Maineri EP, et al. Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes. 2003; 52: 499–505.OdettiPPesceCTraversoNMeniniSMaineriEPComparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes20035249950510.2337/diabetes.52.2.499Search in Google Scholar
Oktem F, Ozguner F, Yilmaz HR, et al. Melatonin reduces urinary excretion of N-acetyl-beta–D-glucosaminidase, albumin and renal oxidative markers in diabetic rats. Clin Exp Pharmacol Physiol. 2006; 33: 95–101.OktemFOzgunerFYilmazHRMelatonin reduces urinary excretion of N-acetyl-beta–D-glucosaminidase, albumin and renal oxidative markers in diabetic rats2006339510110.1111/j.1440-1681.2006.04330.xSearch in Google Scholar
Pal PB, Sinha K, Sil PC. Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats. PLoS One. 2014; 9: e107220.PalPBSinhaKSilPCMangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats20149e10722010.1371/journal.pone.0107220Search in Google Scholar
Prabhakar SS. Role of nitric oxide in diabetic nephropathy. Semin Nephrol. 2004; 24: 333–344.PrabhakarSSRole of nitric oxide in diabetic nephropathy20042433334410.1016/j.semnephrol.2004.04.005Search in Google Scholar
Rajkumar L, Govindarajulu P. Increased degradation of dermal collagen in diabetic rats. Indian J Exp Bio. 1991; 29: 1081–1083.RajkumarLGovindarajuluPIncreased degradation of dermal collagen in diabetic rats19912910811083Search in Google Scholar
Rajkumar V, Ragatzki P, Sima A, Levy J. Enhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infaractions. Endocrine. 1999; 11: 57–60.RajkumarVRagatzkiPSimaALevyJEnhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infaractions199911576010.1385/ENDO:11:1:57Search in Google Scholar
Rosenfeldt FL, Haas SJ, Krum H. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007; 21: 297–306.RosenfeldtFLHaasSJKrumHCoenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials20072129730610.1038/sj.jhh.100213817287847Search in Google Scholar
Rovira-Llopis S, Rocha M, Victor M et al. Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?” ARS. 2013; 19: 1452–1458.Rovira-LlopisSRochaMVictorMIs myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?”2013191452145810.1089/ars.2013.5307379745023521574Search in Google Scholar
Roy S, Trudeau K, Roy S, Behl Y, Dhar S, Chronopoulos A. New insights into hyperglycemia-induced molecular changes in microvascular cells. J Dent Res. 2010; 89: 116–128.RoySTrudeauKRoySBehlYDharSChronopoulosANew insights into hyperglycemia-induced molecular changes in microvascular cells20108911612810.1177/002203450935576520042738Search in Google Scholar
Schena FP and Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 2010; 16: 30–33.SchenaFPGesualdoLPathogenetic mechanisms of diabetic nephropathy201016303310.1681/ASN.200411097015938030Search in Google Scholar
Shimizu MH, Coimbra TM, de Araujo M et al. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int. 2005; 68: 2208–2217.ShimizuMHCoimbraTMde AraujoMN-acetylcysteine attenuates the progression of chronic renal failure2005682208221710.1111/j.1523-1755.2005.00677.x16221220Search in Google Scholar
Sourris K, Harcourt B, Tang P, Morley A, Huynh K, et al. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med. 2012; 52: 716–723.SourrisKHarcourtBTangPMorleyAHuynhKUbiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes20125271672310.1016/j.freeradbiomed.2011.11.01722172526Search in Google Scholar
Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992; 258: 1898–902.StamlerJSSingelDJLoscalzoJBiochemistry of nitric oxide and its redox-activated forms1992258189890210.1126/science.12819281281928Search in Google Scholar
Teoh SL, Abdulatiff A, Das S. Histological changes in the kidneys of experimental diabetic rats fed with Momordicalcharantia (bitter gourd) extract. Rom J MorpholEmbryol. 2010; 51: 91–5.TeohSLAbdulatiffADasSHistological changes in the kidneys of experimental diabetic rats fed with Momordicalcharantia (bitter gourd) extract201051915Search in Google Scholar
Vasavada N and Agarwal R. Role of Oxidative Stress in Diabetic Nephropathy. Adv Chronic Kidney Dis. 2005; 12: 146–154.VasavadaNAgarwalRRole of Oxidative Stress in Diabetic Nephropathy20051214615410.1053/j.ackd.2005.01.00115822050Search in Google Scholar
Vora JP and Ibrahim HAA. Clinical manifestations and natural history of diabetic nephropathy. In: Johnson R and Feehally J: Comprehensive clinical nephrology, 2nd ed. Edinburgh: Mosby; 2003.VoraJPIbrahimHAAClinical manifestations and natural history of diabetic nephropathyIn:JohnsonRFeehallyJ2nd ed.EdinburghMosby2003Search in Google Scholar
Zhang X, Shi Z, Liu Q, Quan H, Cheng X. Effects of coenzyme Q10 intervention on diabetic kidney disease. Medicine. 2019; 98: 1–18.ZhangXShiZLiuQQuanHChengXEffects of coenzyme Q10 intervention on diabetic kidney disease20199811810.1097/MD.0000000000015850658747331192915Search in Google Scholar